1
|
Perréard M, Heutte N, Clarisse B, Humbert M, Leconte A, Géry B, Boisserie T, Dadoun N, Martin L, Blanchard D, Babin E, Bastit V. Head and neck cancer patients under radiotherapy undergoing skin application of hydrogel dressing or hyaluronic acid: results from a prospective, randomized study. Support Care Cancer 2023; 32:7. [PMID: 38055076 DOI: 10.1007/s00520-023-08216-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Accepted: 11/29/2023] [Indexed: 12/07/2023]
Abstract
PURPOSE Acute radiodermatitis (ARD) is a frequent side effect of radiotherapy, a therapeutic option for head and neck squamous cell carcinoma (HNSCC). It is responsible for pain, quality of life (QoL) impairment, and increased risk of treatment discontinuation, which may compromise the prognosis for patients. Local therapies to prevent or alleviate ARD have been proposed without providing any high level of evidence to establish recommendations. METHODS We implemented a prospective multicenter randomized study on patients with HNSCC treated with definitive radiotherapy to assess the impact on ear, nose, and throat (ENT) pain of the application of a hydrogel-based skin dressing (HydroTac®) compared with the application of hyaluronic acid (Ialuset®) during radiotherapy. RESULTS Out of 130 enrolled patients, 48 patients per group were assessable for the main endpoint. No difference between groups was found: a worsening of ENT pain of 3 points or more on a visual analog scale from the initiation to 1 month after the end of the radiotherapy was observed for 8 patients (16.7%) who received HydroTac® compared to 13 patients (27%) who received Ialuset® (p = 0.342). The proportion of patients who experienced ARD and grades of ARD (CTCAE v4.0 criteria) were similar between groups. Patient compliance with radiodermatitis treatment was poor, with 56.1% of patients in the HydroTac® group having their treatment temporarily stopped. CONCLUSION The application of a hydrogel dressing to prevent ARD during radiotherapy for HNSCC patients has failed to demonstrate a benefit. These results may be limited by the difficulties of applying the dressing.
Collapse
Affiliation(s)
- Marion Perréard
- Department of Otolaryngology-Head and Neck Surgery, CHU de Caen, Avenue de La Côte de Nacre, 14000, Caen, France.
- INSERM, U 1086 "Cancer Et Prévention", Avenue de La Côte de Nacre, Caen, France.
| | - Natacha Heutte
- Department of Clinical Research, Center François Baclesse, Avenue du Général Harris, Caen, France
- CETAPS EA3832, Rouen University, Rouen, France
| | - Bénédicte Clarisse
- Department of Clinical Research, Center François Baclesse, Avenue du Général Harris, Caen, France
| | - Maxime Humbert
- Department of Otolaryngology-Head and Neck Surgery, CHU de Caen, Avenue de La Côte de Nacre, 14000, Caen, France
- INSERM, U 1086 "Cancer Et Prévention", Avenue de La Côte de Nacre, Caen, France
| | - Alexandra Leconte
- Department of Clinical Research, Center François Baclesse, Avenue du Général Harris, Caen, France
| | - Bernard Géry
- Department of Radiotherapy, Center François Baclesse, Avenue du Général Harris, Caen, France
| | - Thomas Boisserie
- Centre d'Oncologie Et de Radiothérapie CORT37, Chambray-Lès-Tours, France
| | | | | | | | - Emmanuel Babin
- Department of Otolaryngology-Head and Neck Surgery, CHU de Caen, Avenue de La Côte de Nacre, 14000, Caen, France
- INSERM, U 1086 "Cancer Et Prévention", Avenue de La Côte de Nacre, Caen, France
| | - Vianney Bastit
- Department of Otolaryngology-Head and Neck Surgery, CHU de Caen, Avenue de La Côte de Nacre, 14000, Caen, France
- INSERM, U 1086 "Cancer Et Prévention", Avenue de La Côte de Nacre, Caen, France
- Department of Head and Neck Surgery, Center François Baclesse, Avenue du Général Harris, Caen, France
| |
Collapse
|
2
|
Hassen BME, Haimedah ED, Hachem MAM. Epidemiological Aspects and Anatomopathological of Ear Nose and Throat (ENT) and Cervico-Facial (CF) Cancers at the Military Hospital of Nouakchott. Health (London) 2021. [DOI: 10.4236/health.2021.1310081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
3
|
Essawy MM, El-Sheikh SM, Raslan HS, Ramadan HS, Kang B, Talaat IM, Afifi MM. Function of gold nanoparticles in oral cancer beyond drug delivery: Implications in cell apoptosis. Oral Dis 2020; 27:251-265. [PMID: 32657515 DOI: 10.1111/odi.13551] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Revised: 06/30/2020] [Accepted: 07/06/2020] [Indexed: 02/06/2023]
Abstract
OBJECTIVES Gold nanoparticles (AuNPs) are used to deliver drugs and therapeutic small molecule inhibitors to cancer cells. Evidence shows that AuNPs coated with nuclear localization sequence can cross the nuclear membrane and induce cellular apoptosis. To determine the therapeutic role of AuNPs, we compared two nanoconstructs conjugated to doxorubicin (DOX) through pH-sensitive and pH-resistant linkers. MATERIALS AND METHODS We tested DOX nanoconjugates' cytotoxicity, cellular and nuclear uptake in oral squamous cell carcinoma cell line. Furthermore, we evaluated the therapeutic effect of pH-sensitive and pH-resistant DOX bioconjugates in hamster buccal pouch carcinoma model. RESULTS Our data indicate that pH-resistant and pH-sensitive DOX-nanoconjugates were equally localized in cancer cells, but the pH-resistant DOX nanoparticles were more localized in the nuclei inducing a 2-fold increase in the apoptotic effect compared with the pH-sensitive DOX nanoparticles. Our in vivo results show significantly higher tumor shrinkage and survival rates in animals treated with DOX pH-resistant AuNPs compared with pH-sensitive ones. CONCLUSION Our findings suggest that AuNPs enhance the cytotoxic effect against cancer cells in addition to acting as drug carriers. DOX pH-resistant AuNPs enhanced accumulation of AuNPs in cancer cells' nuclei inducing a significant cellular apoptosis which was confirmed using in vitro and in vivo experiments without deleterious effects on blood cell count.
Collapse
Affiliation(s)
- Marwa M Essawy
- Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Egypt.,Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria University, Egypt
| | - Sahar M El-Sheikh
- Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Egypt
| | - Hanaa S Raslan
- Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Egypt
| | - Heba S Ramadan
- Medical Biophysics Department, Medical Research Institute, Alexandria University, Egypt
| | - Bin Kang
- Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA
| | - Iman M Talaat
- Clinical Sciences Department, College of Medicine, University of Sharjah, UAE.,Pathology Department, Faculty of Medicine, Alexandria University, Egypt
| | - Marwa M Afifi
- Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Egypt.,Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
| |
Collapse
|
4
|
Brenet E, Barbe C, Hoeffel C, Dubernard X, Merol JC, Fath L, Servagi-Vernat S, Labrousse M. Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy. Cancers (Basel) 2020; 12:cancers12051234. [PMID: 32422975 PMCID: PMC7281260 DOI: 10.3390/cancers12051234] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 05/04/2020] [Accepted: 05/10/2020] [Indexed: 12/14/2022] Open
Abstract
Aims: To investigate the predictive capacity of early post-treatment diffusion-weighted magnetic resonance imaging (MRI) for recurrence or tumor progression in patients with no tumor residue after chemo-radiotherapy (CRT) for head and neck squamous cell carcinoma, and, to assess the predictive capacity of pre-treatment diffusion-weighted MRI for persistent tumor residue post-CRT. Materials and Method: A single center cohort study was performed in one French hospital. All patients with squamous cell carcinoma receiving CRT (no surgical indication) were included. Two diffusion-weighted MRI were performed: one within 8 days before CRT and one 3 months after completing CRT with determination of median tumor apparent diffusion coefficient (ADC). Main outcome: The primary endpoint was progression-free survival. Results: 59 patients were included prior to CRT and 46 (78.0%) completed CRT. A post-CRT tumor residue was found in 19/46 (41.3%) patients. In univariate analysis, initial ADC was significantly lower in patients with residue post CRT (0.56 ± 0.11 versus 0.79 ± 0.13; p < 0.001). When initial ADC was dichotomized at the median, initial ADC lower than 0.7 was significantly more frequent in patients with residue post CRT (73.7% versus 11.1%, p < 0.0001). In multivariate analysis, only initial ADC lower than 0.7 was significantly associated with tumor residue (OR = 22.6; IC [4.9–103.6], p < 0.0001). Among 26 patients without tumor residue after CRT and followed up until 12 months, 6 (23.1%) presented recurrence or progression. Only univariate analysis was performed due to a small number of events. The only factor significantly associated with disease progression or early recurrence was the delta ADC (p = 0.0009). When ADC variation was dichotomized at the median, patients with ADC variation greater than 0.7 had time of disease-free survival significantly longer than patients with ADC variation lower than 0.7 (377.5 [286–402] days versus 253 [198–370], p < 0.0001). Conclusion and relevance: Diffusion-weighted MRI could be a technique that enables differentiation of patients with high potential for early recurrence for whom intensive post-CRT monitoring is mandatory. Prospective studies with more inclusions would be necessary to validate our results.
Collapse
Affiliation(s)
- Esteban Brenet
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France; (X.D.); (J.-C.M.); (M.L.)
- Correspondence:
| | - Coralie Barbe
- Clinical Research Unit, Robert Debré University Hospital, 51100 Reims, France;
| | - Christine Hoeffel
- Department of Radiology, Robert Debré University Hospital, 51100 Reims, France;
| | - Xavier Dubernard
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France; (X.D.); (J.-C.M.); (M.L.)
| | - Jean-Claude Merol
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France; (X.D.); (J.-C.M.); (M.L.)
| | - Léa Fath
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University Hospital of Strasbourg, 67000 Strasbourg, France;
| | | | - Marc Labrousse
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France; (X.D.); (J.-C.M.); (M.L.)
| |
Collapse
|
5
|
Le Flem M, Santini L, Boulze C, Alshukry A, Giovanni A, Dessi P, Fakhry N. Early oral hydration protects against pharyngocutaneous fistula after total laryngectomy or total pharyngolaryngectomy. Head Neck 2020; 42:1902-1906. [DOI: 10.1002/hed.26122] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Revised: 01/24/2020] [Accepted: 02/11/2020] [Indexed: 12/20/2022] Open
Affiliation(s)
- Matthieu Le Flem
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Laure Santini
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Carole Boulze
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Abdallah Alshukry
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Antoine Giovanni
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Patrick Dessi
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| | - Nicolas Fakhry
- Head and Neck SurgeryUniversitary Hospital La Conception Marseille France
| |
Collapse
|
6
|
Aires FT, Dedivitis RA, Kulcsar MAV, Ramos DM, Cernea CR. Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy. ACTA OTORHINOLARYNGOLOGICA ITALICA 2019; 38:31-37. [PMID: 29756613 DOI: 10.14639/0392-100x-1572] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2017] [Accepted: 03/11/2017] [Indexed: 01/10/2023]
Abstract
SUMMARY The role of systemic inflammatory response as a prognostic factor has been proposed in a variety of cancers. The purpose of this study was to investigate the prognostic value of the pretreatment neutrophil-to-lymphocyte ratio (NLR) in the incidence of pharyngocutaneous fistula (PCF) in patients who underwent total laryngectomy. We conducted a retrospective cohort analysis of 141 patients with squamous cell carcinoma of larynx who underwent total laryngectomy from 2009 to 2015. The incidence of PCF was 49.6%. A higher risk of 23% was observed among patients with NLR > 2.5 for the occurrence of PCF (p = 0.007). Patients with laryngeal squamous cell carcinoma who present elevated values in the ration > LR> (> 2.5) presented a higher risk of developing pharyngocutaneous fistula in the postoperative setting of total laryngectomy.
Collapse
Affiliation(s)
- F T Aires
- Department of Head and Neck Surgery, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil
| | - R A Dedivitis
- Department of Head and Neck Surgery, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil
| | - M A V Kulcsar
- Department of Head and Neck Surgery, Instituto do Cancer do Estado de Sao Paulo ICESP, São Paulo, Brazil
| | - D M Ramos
- Department of Head and Neck Surgery, Instituto do Cancer do Estado de Sao Paulo ICESP, São Paulo, Brazil
| | - C R Cernea
- Department of Head and Neck Surgery, University of São Paulo School of Medicine, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
7
|
Abstract
Les cancers des voies aérodigestives supérieures (VADS) sont majoritairement des cancers masculins. Ils sont associés avant tout à une consommation excessive d'alcool et de tabac. Ils apparaissent comme des sociopathologies. Les répercussions psychosociales de ces cancers se manifestent par des trajectoires de vie difficiles et une dégradation des relations au sein du couple. Ces constatations incitent à mettre en œuvre des politiques de santé contre le tabagisme et à proposer des recherches pour réduire l'incidence de ces cancers.
Collapse
|
8
|
Epidemiological Aspects in Lip Tumors in Oltenia Region of Romania During 2012-2016. CURRENT HEALTH SCIENCES JOURNAL 2018; 44:39-47. [PMID: 30622754 PMCID: PMC6295190 DOI: 10.12865/chsj.44.01.07] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/04/2018] [Accepted: 03/21/2018] [Indexed: 12/02/2022]
Abstract
Purpose. The objective of this study was to review lip tumor diagnosed subjects from Oltenia
region, in the past 5 years according to gender, age, home environment,
profession, geographic area, smoking habit, associated diseases, tumor location,
macroscopic aspect and histological type. Material and Methods. The study was
done at the Oral and Maxillo-Facial Clinic of the Emergency Clinical County
Hospital of Craiova, and involved the analysis of patient file records, surgical
registers, histopathological bulletins, from 2012-2016. Results. Of the 175
subjects included in this study, all of them diagnosed with lip tumor pathology,
109 (62.29%) were men, and 66 (37.71%) were women, all of
them with ages between 6 and 92 years, with a mean age of 61 years. Distribution
of study participants according to the home residence showed that majority of
the subjects lived in rural area. The most frequently localization of lip tumors
in study participants was at the lower lip-140 cases (80%), than at
the upper lip-35 cases (20%).According to histological
characteristics, distribution of the malignant lip tumors was
87.39%-squamous cell carcinoma (SCC), 5.41%-basal cell
carcinoma (BCC) and 7.20%-other type of tumors. Conclusions. The
lower lip was the most affected, by lip cancer, and squamous cell carcinoma
represents the most frequently histological type of these tumors.
Collapse
|
9
|
Perri F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, Di Biase A, Romanelli P, Buonerba C, Di Lorenzo G, Daponte A, Caponigro F, Pisconti S, Pacelli R, Ravo V, Muto P, Solla R. Locally advanced paranasal sinus carcinoma: A study of 30 patients. Oncol Lett 2017; 13:1338-1342. [PMID: 28454258 PMCID: PMC5403341 DOI: 10.3892/ol.2017.5598] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Accepted: 05/23/2016] [Indexed: 12/13/2022] Open
Abstract
Sinonasal carcinomas (SNcs) are rare neoplasms arising from the paranasal sinuses and nasal cavity. Although these tumours have a heterogeneous histology, they are commonly diagnosed as a locally advanced disease and are associated with a poor prognosis. The present retrospective study reviewed 30 patients with locally advanced SNc, who were treated with surgery followed by chemoradiotherapy or radiotherapy, or radiotherapy with or without concomitant chemotherapy between January 1999 and January 2013 at the Department of Radiation Therapy, University of Naples 'Federico II' (Naples, Italy). A total of 19 patients were treated with upfront surgery followed by adjuvant radio- or chemoradiotherapy (group A), while the remaining 11 patients received exclusive radiotherapy with or without concomitant chemotherapy (group B). Concurrent cisplatin-based chemotherapy (100 mg/m2, days 1, 22 and 43 for 3 cycles) was administered to 34% of patients in group A and 55% of patients in group B. At a median follow-up of 31 months, 33.3% of patients were alive. Cause-specific survival (CSS) and progression-free survival (PFS) times were 32 and 12 months, respectively. No difference in CSS rate was observed between the two treatment groups. Univariate analysis determined that disease stage was the only factor that significantly affected CSS (P=0.002) and PFS (P=0.0001) rates. Acute and chronic toxicities were mild, with only 23.3% of patients reporting G1-2 side effects and no treatment-related blindness. The present study reported moderate activity and efficacy of surgery followed by adjuvant radio- or chemoradiotherapy, and exclusive radiotherapy with or without chemotherapy in this poor prognosis category of patients.
Collapse
Affiliation(s)
- Francesco Perri
- Medical Oncology Unit, ‘Santissima Annunziata’ Hospital, I-74100 Taranto, Italy
| | - Raffaele Addeo
- Oncology Unit, ‘ASL Napoli 2 Nord’, San Giovanni di Dio Hospital, I-80027 Naples, Italy
| | - Manuel Conson
- Department of Radiation Therapy, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | - Adriana Faiella
- Department of Radiation Therapy, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | | | - Gabriella Torre
- Department of Radiation Therapy, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | - Angela Di Biase
- Department of Radiation Therapy, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | - Paola Romanelli
- Department of Radiation Therapy, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | - Carlo Buonerba
- Oncological Referral Center of Basilicata, The Institute for Research, Hospitalization and Health Care, Rionero in Vulture, I-85028 Potenza, Italy
| | - Giuseppe Di Lorenzo
- Department of Endocrinology and Molecular and Clinical Oncology, University of Naples ‘Federico II’, I-80131 Naples, Italy
| | - Antonio Daponte
- Head and Neck Medical Oncology Unit, National Tumour Institute of Naples, The Institute for Research, Hospitalization and Health Care ‘Fondazione Giovanni Pascale’, I-80131 Naples, Italy
| | - Francesco Caponigro
- Head and Neck Medical Oncology Unit, National Tumour Institute of Naples, The Institute for Research, Hospitalization and Health Care ‘Fondazione Giovanni Pascale’, I-80131 Naples, Italy
| | - Salvatore Pisconti
- Medical Oncology Unit, ‘Santissima Annunziata’ Hospital, I-74100 Taranto, Italy
| | - Roberto Pacelli
- Oncology Unit, ‘ASL Napoli 2 Nord’, San Giovanni di Dio Hospital, I-80027 Naples, Italy
| | - Vincenzo Ravo
- Department of Radiotherapy, The Foundation Institute for Research, Hospitalization and Health Care ‘Istituto Nazionale dei Tumori’, I-80131 Naples, Italy
| | - Paolo Muto
- Department of Radiotherapy, The Foundation Institute for Research, Hospitalization and Health Care ‘Istituto Nazionale dei Tumori’, I-80131 Naples, Italy
| | - Raffaele Solla
- Institute of Biostructure and Bioimaging, National Council of Research, I-80128 Naples, Italy
| |
Collapse
|
10
|
Amana B, Foma W, Pegbessou E, Bissa H, Adam S, Amana E, Amégbor K, Boko E, Kpemissi E. [Primitive oto-rhino-laryngology and cervico-maxillofacial tumors: epidemiological and histological aspects]. Pan Afr Med J 2016; 25:47. [PMID: 28250871 PMCID: PMC5321144 DOI: 10.11604/pamj.2016.25.47.9953] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2016] [Accepted: 07/28/2016] [Indexed: 11/22/2022] Open
Abstract
Introduction Notre objectif a été d'établir le panorama des cancers primitifs oto-rhino-laryngologiques et cervico-maxillo-faciaux dans un service de référence au Togo. Méthodes Il s’est agi d’une étude rétrospective descriptive, portant sur les cancers diagnostiqués dans le service d’ORL et de chirurgie cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé. Elle a été réalisée sur une période de 10 ans (1er Janvier 2005 au 31 Décembre 2014). Résultats Les cancers ORL et cervico-maxillo-faciaux représentaient 0,48% des consultations et 15,3% de l’ensemble des tumeurs ORL. L’âge moyen des patients était de 47 ans, avec des extrêmes de 3 mois et 86 ans. On notait une prédominance masculine; la sex-ratio était de 1,45. L’alcoolotabagisme prédominait dans le cancer du larynx. Les cancers des voies aérodigestives supérieures (VADS) ont représenté 64,8%, avec une prédominance des cancers de la cavité buccale (36,2% des VADS), suivi des cancers de l’oropharynx (18,5% des VADS) puis des cancers du larynx (18,1% des VADS). Les adénopathies cervicales malignes primitives représentaient 18%. Les lésions les plus rares étaient les cancers de l’oreille et du tissu osseux maxillo-mandibulaire (2,24% chacun). L’histologie était dominée par le carcinome épidermoïde (61,4%) suivi du lymphome non hodgkinien (23,2%). Conclusion Les cancers ORL et cervico-maxillo-faciaux sont fréquents au Togo et diagnostiqués à tout âge. Les cancers prédominants sont ceux de la cavité buccale, du pharynx et les adénopathies cervicales malignes primitives.
Collapse
Affiliation(s)
- Bathokedeou Amana
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Winga Foma
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Essobozou Pegbessou
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Haréfétéguéna Bissa
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Saliou Adam
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Essobiziou Amana
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| | - Koffi Amégbor
- Laboratoire d'Anatomie Pathologique du CHU Sylvanus Olympio de Lomé, Togo
| | | | - Eyawèlohn Kpemissi
- Service d'ORL et Chirurgie Cervico-maxillo-faciale du CHU Sylvanus Olympio de Lomé, Togo
| |
Collapse
|
11
|
Moya M. [Psychological care of patients with head and neck cancer]. SOINS; LA REVUE DE REFERENCE INFIRMIERE 2015; 60:50-52. [PMID: 26369747 DOI: 10.1016/j.soin.2015.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Treatments for head and neck cancers are generally complex and debilitating. Surgery, often mutilating, profoundly affects the relationship between oneself and others and causes verbal communication, breathing and swallowing difficulties. The functional and aesthetic sequelae are a constant reminder to the patient of the disease and make them conscious of their appearance.
Collapse
Affiliation(s)
- Mélanie Moya
- Service de psychiatrie adulte, centre hospitalier intercommunal Lucie et Raymond Aubrac, 40, allée de la Source, 94195 Villeneuve-Saint-Georges cedex, France.
| |
Collapse
|
12
|
Biau J, Chautard E, Miroir J, Lapeyre M. [Radioresistance parameters in head and neck cancers and methods to radiosensitize]. Cancer Radiother 2015; 19:337-46; quiz 360-1, 363. [PMID: 26119219 DOI: 10.1016/j.canrad.2015.02.014] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2014] [Revised: 02/06/2015] [Accepted: 02/12/2015] [Indexed: 12/24/2022]
Abstract
Head and neck cancers have been widely studied concerning their sensitivity to radiation therapy. Several parameters affect tumour response to radiation therapy. Some parameters are linked to the tumour. Large or invasive tumours, localization, such as oral cavity or adenopathy, are factors of radioresistance. Others parameters are linked to the patients themselves. Tobacco intoxication during radiotherapy and a low hemoglobin level contribute to radioresistance. More recently, a positive human papilloma virus (HPV) status has been reported to positively affect radiosensitivity. Finally, other parameters are related to tumour biology. Hypoxia, intrinsic radiosensitivity of tumour cells, tumour differentiation and repopulation (provided by Ki-67 index or EGFR level) are components of radiosensitivity. Currently, concurrent chemoradiotherapy is one of the gold standard treatments to overcome clinical outcome of locally advanced head and neck cancer. This combination increases locoregional control and survival. Taxane-based induction chemotherapy can also be an alternative. Another validated approach is the association of radiotherapy with cetuximab (EGFR targeting) but only one randomized study has been published. Fractionation modifications, especially hyperfractionation, have given positive results on both tumour control and survival. Strategies targeting hypoxia improve locoregional control but have less clinical impact.
Collapse
Affiliation(s)
- J Biau
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France; EA7283 Cancer Resistance Exploring and Targeting (CREAT), Clermont université, université d'Auvergne, 49, boulevard François-Mitterrand, CS 60032, 63001 Clermont-Ferrand cedex 1, France; Équipe recombinaison, réparation et cancer, UMR 3347, CNRS, centre universitaire, 91405 Orsay cedex, France; Inserm U1021, centre universitaire, 91405 Orsay cedex, France; Institut Curie, 26, rue d'Ulm, 75005 Paris, France.
| | - E Chautard
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France; EA7283 Cancer Resistance Exploring and Targeting (CREAT), Clermont université, université d'Auvergne, 49, boulevard François-Mitterrand, CS 60032, 63001 Clermont-Ferrand cedex 1, France
| | - J Miroir
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France
| | - M Lapeyre
- Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand cedex 1, France
| |
Collapse
|
13
|
Fernández A, Córdova P, Badenier O, Esguep A. Epidemiological characterization of oral cancer. Literature review. JOURNAL OF ORAL RESEARCH 2015. [DOI: 10.17126/joralres.2015.027] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
14
|
De Felice F, Musio D, Terenzi V, Valentini V, Cassoni A, Tombolini M, De Vincentiis M, Tombolini V. Treatment improvement and better patient care: which is the most important one in oral cavity cancer? Radiat Oncol 2014; 9:263. [PMID: 25479896 PMCID: PMC4263000 DOI: 10.1186/s13014-014-0263-x] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2014] [Accepted: 11/15/2014] [Indexed: 11/10/2022] Open
Abstract
Due to substantial improvement in diagnosis and treatment of oral cavity cancer, a better understanding of the patient care needs to be revised. We reviewed literature related to OCC and discussed current general management approaches and related long-term radiation toxicities to emphasize the multidisciplinary team involvement. New technical modalities and patient quality of life parameters should be an integral and paramount state in the clinical evaluation to significantly contribute to reduce secondary side effects.
Collapse
Affiliation(s)
- Francesca De Felice
- Department of Radiotherapy, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Daniela Musio
- Department of Radiotherapy, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Valentina Terenzi
- Department of Maxillofacial Surgery, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Valentino Valentini
- Department of Maxillofacial Surgery, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Andrea Cassoni
- Department of Maxillofacial Surgery, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Mario Tombolini
- Department Organs of Sense, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Marco De Vincentiis
- Department Organs of Sense, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
| | - Vincenzo Tombolini
- Department of Radiotherapy, Policlinico Umberto I "Sapienza", University of Rome, Viale Regina Elena 326, 00161, Rome, Italy. .,Spencer-Lorillard Foundation, Viale Regina Elena 262, 00161, Rome, Italy.
| |
Collapse
|